You’ll find here the latest news and insights about Real4Reg.
If you want to receive all updates directly in your email inbox, you can subscribe to our newsletter. Additionally, feel free to explore our archive for past newsletters.
-
Project Coordinator’s Visits to Consortium Partners Enhances Collaboration within Real4Reg
The recent series of visits by our project coordinator Kerstin Pfeifer (BfArM, Germany) to all work package (WP) leaders has significantly reinforced collaboration and innovation within the Real4Reg project. Since she joined Real4Reg ten months into the project, these visits provided an in-depth overview of the partners’ work and their teams. The focus of the…
-
Patient Associations – Empowering Patients in Medical Research and Real-World Data Use
In recent years, patient associations have emerged as pivotal players in medical research, contributing invaluable insights and driving innovations that resonate with patient needs. These organisations, often founded and led by individuals directly affected by specific conditions, bring a unique perspective that traditional research teams may lack. That’s the case with our partner EUpALS. To…
-
Use of Real World Evidence (RWE) for regulatory purposes
While randomized controlled trials (RTCs) are the gold standard for generating evidence for regulatory decision making in the product lifecycle of drugs , some of the limitations by RTCs may be addressed by the use of real world evidence (RWE). RWE is information derived from the analysis of real-world data (RWD). While internal validity is…